HC Wainwright Reaffirms “Neutral” Rating for Inovio Pharmaceuticals (NASDAQ:INO)
HC Wainwright reiterated their neutral rating on shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) in a research report report published on Monday, Benzinga reports. HC Wainwright currently has a $15.00 price target on the biopharmaceutical company’s stock. Several other research firms have also recently commented on INO. Stephens began coverage on shares of Inovio […]
More Stories
Synairgen (LON:SNG) Stock Price Down 0.9% – What’s Next?
Synairgen plc (LON:SNG – Get Free Report) shares fell 0.9% on Wednesday . The stock traded as low as GBX...
Victoria (LON:VCP) Trading Down 7.8% – Here’s What Happened
Victoria PLC (LON:VCP – Get Free Report) traded down 7.8% on Wednesday . The company traded as low as GBX...
Azincourt Energy (CVE:AAZ) Stock Price Up 50% – Still a Buy?
Shares of Azincourt Energy Corp. (CVE:AAZ – Get Free Report) shot up 50% during mid-day trading on Wednesday . The...
Genus (LON:GNS) Reaches New 1-Year Low – Time to Sell?
Genus plc (LON:GNS – Get Free Report)’s share price hit a new 52-week low on Wednesday . The stock traded...
Southern Empire Resources (CVE:SMP) Shares Up 50% – Time to Buy?
Southern Empire Resources Corp. (CVE:SMP – Get Free Report) shares were up 50% during trading on Wednesday . The stock...
Azincourt Energy (CVE:AAZ) Shares Up 50% – Still a Buy?
Azincourt Energy Corp. (CVE:AAZ – Get Free Report)’s share price shot up 50% during mid-day trading on Wednesday . The...